Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. IMD-1-0241
Published by: International Institute for Management Development (IMD)
Originally published in: 2005
Version: 24.10.2016
Revision date: 05-Jan-2017
Length: 17 pages
Data source: Field research

Abstract

This is the second of a three-case series (IMD-1-0240 to IMD-1-0242). Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyse and structure the next financing round. Venture Valuation has to, given a very tight deadline, customise the evaluation process to using quantitative and qualitative data to best meet its customers needs. The case outlines the task ahead of Venture Valuation and requires students to make assessments and calculations and finally come up with a valuation for the start-up, Genedata.
Location:
Size:
Small, start-up
Other setting(s):
July 1999

About

Abstract

This is the second of a three-case series (IMD-1-0240 to IMD-1-0242). Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyse and structure the next financing round. Venture Valuation has to, given a very tight deadline, customise the evaluation process to using quantitative and qualitative data to best meet its customers needs. The case outlines the task ahead of Venture Valuation and requires students to make assessments and calculations and finally come up with a valuation for the start-up, Genedata.

Settings

Location:
Size:
Small, start-up
Other setting(s):
July 1999

Related